A prominent medical expert has condemned an upcoming clinical trial as "wholly unethical," arguing that its design raises serious ethical concerns. The criticism centers on potential risks to participants and whether the trial meets fundamental standards of medical ethics. Questions have been raised about whether the trial could expose subjects to unnecessary harm or fail to provide meaningful benefits. The debate highlights growing tensions over the boundaries of scientific research and patient safety.
“It’s a wholly unethical trial, and it shouldn’t be allowed,” says Dr. Paul Offit
